🔗 Permalink

Inventor profile of:

Mark LARCHE

City:

Ontario

Country:

Canada

Published Applications:

Last publication date:

2017-06-08

Top Assignees for applications by Mark LARCHE

The entities that hold a legal rights for patent applications filed by inventor LARCHE Mark:

CIRCASSIA LIMITED 10 OXFORD, United Kingdom

Recent patent applications by LARCHE Mark

Mark LARCHE from Ontario, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-06-08

US20170157226A1

Human necessities

Peptide for vaccine

#2 | 2017-01-19

US20170014505A1

Human necessities

VACCINE COMPRISING AMB A 1 PEPTIDES FOR USE IN THE TREATMENT OF RAGWEED ALLERGY

#3 | 2016-10-06

US20160289281A1

Chemistry; metallurgy

PEPTIDE WITH MULTIPLE EPITOPES

#4 | 2015-08-06

US20150218215A1

Chemistry; metallurgy

Cladosporium peptides

#5 | 2015-04-09

US20150098969A1

Chemistry; metallurgy

ALTERNARIA PEPTIDES

#6 | 2014-11-06

US20140328868A1

Human necessities

T-CELL ANTIGEN PEPTIDE FROM ALLERGEN FOR STIMULATION OF IL-10 PRODUCTION

#7 | 2014-10-09

US20140302071A1

Human necessities

PEPTIDES FOR VACCINE

#8 | 2014-07-03

US20140186403A1

Chemistry; metallurgy

PEPTIDE FOR VACCINE

#9 | 2013-11-07

US20130295123A1

Human necessities

Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy

#10 | 2012-06-14

US20120148612A1

Human necessities

Grass peptides for vaccine

#11 | 2012-05-03

US20120108524A1

Human necessities

Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy

#12 | 2011-08-25

US20110206709A1

Human necessities

T-cell antigen peptide from allergen for stimulation of IL-10 production

#13 | 2010-11-25

US20100298239A1

Human necessities

Peptide with multiple epitopes

#14 | 2010-10-14

US20100260805A1

Human necessities

Peptide for vaccine

#15 | 2010-09-23

US20100239599A1

Human necessities

Vaccine peptide combinations against cat allergy

InventorID:

518043 ⎘